STRO vs PRTH Comparison

Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. Company's wholly-owned product candidate is STRO-004, a single homogeneous ADC directed against tissue factor which are developing for the treatment of solid tumors. The company also pipeline contains STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.

Priority Technology Holdings Inc is a fintech company that provides payment and banking-related solutions, including services for collecting, storing, lending, and transferring money for businesses. The company has three reportable segments: i) Merchant Solutions: Provides full-service acquiring and payment-enabled solutions for B2C transactions, ii) Payables: Provides AP automation solutions to corporations, software partners and FIs in addition to improving cash flows by providing instant access to working capital and iii) Treasury Solutions: Provides embedded finance and BaaS solutions to customers to modernize legacy platforms and accelerate software partners' strategies to monetize payments. The majority of the company's revenue is derived from the Merchant Solutions segment.